Total Valuation
Shinpoong Pharmaceutical Co., Ltd. has a market cap or net worth of ₩392.19B. The enterprise value is ―.
Market Cap₩392.19B
Enterprise Value―
Share Statistics
Shinpoong Pharmaceutical Co., Ltd. has 52,418,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,418,520
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shinpoong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 4.29%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.29%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee287.95M
Profits Per Employee10.83M
Employee Count815
Asset Turnover0.67
Inventory Turnover2.26
Valuation Ratios
The current PE Ratio of Shinpoong Pharmaceutical Co., Ltd. is 38.0. Shinpoong Pharmaceutical Co., Ltd.’s PEG ratio is -0.52.
PE Ratio38.0
PS Ratio3.30
PB Ratio2.87
Price to Fair Value2.87
Price to FCF56.24
Price to Operating Cash Flow17.48
PEG Ratio-0.52
Income Statement
In the last 12 months, Shinpoong Pharmaceutical Co., Ltd. had revenue of 234.68B and earned 8.83B in profits. Earnings per share was 172.00.
Revenue234.68B
Gross Profit102.37B
Operating Income14.26B
Pretax Income8.45B
Net Income8.83B
EBITDA25.65B
Earnings Per Share (EPS)172.00
Cash Flow
In the last 12 months, operating cash flow was 23.44B and capital expenditures -3.08B, giving a free cash flow of 20.36B billion.
Operating Cash Flow23.44B
Free Cash Flow20.36B
Free Cash Flow per Share388.46
Dividends & Yields
Shinpoong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change-40.65%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)75.53K
Important Dates
Shinpoong Pharmaceutical Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Shinpoong Pharmaceutical Co., Ltd. as a current ratio of 3.09, with Debt / Equity ratio of 18.70%
Current Ratio3.09
Quick Ratio2.22
Debt to Market Cap0.07
Net Debt to EBITDA0.33
Interest Coverage Ratio5.30
Taxes
In the past 12 months, Shinpoong Pharmaceutical Co., Ltd. has paid 62.48M in taxes.
Income Tax62.48M
Effective Tax Rate<0.01
Enterprise Valuation
Shinpoong Pharmaceutical Co., Ltd. EV to EBITDA ratio is 30.54, with an EV/FCF ratio of 56.85.
EV to Sales3.34
EV to EBITDA30.54
EV to Free Cash Flow56.85
EV to Operating Cash Flow45.39
Balance Sheet
Shinpoong Pharmaceutical Co., Ltd. has ₩76.60B in cash and marketable securities with ₩54.51B in debt, giving a net cash position of ₩22.09B billion.
Cash & Marketable Securities₩76.60B
Total Debt₩54.51B
Net Cash₩22.09B
Net Cash Per Share₩421.43
Tangible Book Value Per Share₩4.81K
Margins
Gross margin is 43.55%, with operating margin of 6.07%, and net profit margin of 3.76%.
Gross Margin43.55%
Operating Margin6.07%
Pretax Margin3.60%
Net Profit Margin3.76%
EBITDA Margin10.93%
EBIT Margin6.07%
Analyst Forecast
The average price target for Shinpoong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.08%
EPS Growth Forecast―